TORONTO, May 15, 2024 /CNW/ - Frank Gleeson Co-Founder and Chief Executive Officer, Satellos Bioscience Inc. (TSX: MSCL) ("Satellos" or the "Company"), and his team joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market and celebrate the Company's graduation to TSX.
Satellos is a publicly traded biotechnology company dedicated to developing life-improving medicines to treat degenerative muscle diseases. For more information, visit www.satellos.com.
CNW sponsored announcement. To learn more visit www.newswire.ca.
SOURCE Toronto Stock Exchange
MEDIA CONTACT: Jessica Yingling, [email protected], 1-858-344-8091
Share this article